Mind over tumor: short therapy may improve chemo response in breast cancer
NCT ID NCT07570368
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a short psychological therapy called Brief Acceptance and Commitment Therapy (Brief-ACT) can help chemotherapy work better in women with locally advanced breast cancer. Fifty-four participants will either receive standard chemotherapy alone or with Brief-ACT sessions. Researchers will measure tumor response, stress levels, and blood markers of inflammation and blood vessel growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Brief Acceptance and Commitment Therapy (Brief-ACT)
What this could lead to
If it works, this could show that adding a short psychological therapy to standard chemotherapy improves tumor response and reduces stress in breast cancer patients.
What could go wrong
This is a small, early-stage trial with only 54 participants, so results may not apply to all patients. The therapy may not significantly affect chemotherapy outcomes or biomarker levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••